HROW — Harrow Health Inc

Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on NASDAQ. It is led by Mark L. Baum J.D., based in 1A Burton Hills Boulevard, Nashville, TN, United States, 37215, with about 382 employees. Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; MAXIDEX and FLAREX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe and the eye; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and NATACYN, a sterile, antifungal drug for the treatment of fungal blepharitis, conjunctivitis, and keratitis. In addition, it offers TOBRADEX ST, a tobramycin and dexamethasone ophthalmic suspension; VERKAZIA cyclosporine ophthalmic emulsion; NEVANAC, a non-steroidal, anti-inflammatory eye drop; and FRESHKOTE preservative free (PF) is a lubricant eye drop. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee.

Latest reported HROW revenue for 2025-09-30 was $71.6M. Net income was $1.0M. Revenue was up 12.4% from 2025-06-30 to 2025-09-30. HROW currently screens at market cap $1.28B.

Use this HROW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the HROW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the HROW SEC filings page. Lician reads the product cache first so this HTML stays unique to Harrow Health Inc even when a live quote feed is slow.